Global Alpha- Antitrypsin Deficiency Treatment Market 2018 - Cost Analysis, Revenue and Gross Margin Analysis with Its Important Types and Application

 Buy Now

   Published Date : Jun-2018   |    Format : PDF   |    Pages : 114
This report studies the global Alpha- Antitrypsin Deficiency Treatment market status and forecast, categorizes the global Alpha- Antitrypsin Deficiency Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Alpha- Antitrypsin Deficiency Treatment market is valued at  million US$ in 2017 and will reach  million US$ by the end of 2025, growing at a CAGR of  during 2018-2025.

The major players covered in this report
    Adverum Biotechnologies, Inc.
    Alnylam Pharmaceuticals, Inc.
    Applied Genetic Technologies Corporation
    Arrowhead Pharmaceuticals, Inc.
    Carolus Therapeutics, Inc.
    Cevec Pharmaceuticals GmbH
    Dicerna Pharmaceuticals, Inc.
    Digna Biotech, S.L.
    Editas Medicine, Inc.
    Grifols, S.A.
    Inhibrx
    Intellia Therapeutics, Inc.
    International Stem Cell Corporation
    Ionis Pharmaceuticals, Inc.
    Kamada Ltd.
    Polyphor Ltd.
    ProMetic Life Sciences Inc.
    rEVO Biologics, Inc.
    Sangamo BioSciences, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    CT-2009
    POL-6014
    ARO-AAT
    ALNAAT-02
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Others

The study objectives of this report are:
    To analyze and study the global Alpha- Antitrypsin Deficiency Treatment sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Alpha- Antitrypsin Deficiency Treatment players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alpha- Antitrypsin Deficiency Treatment are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Alpha- Antitrypsin Deficiency Treatment Manufacturers
Alpha- Antitrypsin Deficiency Treatment Distributors/Traders/Wholesalers
Alpha- Antitrypsin Deficiency Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Alpha- Antitrypsin Deficiency Treatment market, by end-use.
Detailed analysis and profiles of additional market players.

Global Alpha- Antitrypsin Deficiency Treatment Sales Market Report 2018
1 Alpha- Antitrypsin Deficiency Treatment Market Overview
    1.1 Product Overview and Scope of Alpha- Antitrypsin Deficiency Treatment
    1.2 Classification of Alpha- Antitrypsin Deficiency Treatment by Product Category
        1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 CT-2009
        1.2.4 POL-6014
        1.2.5 ARO-AAT
        1.2.6 ALNAAT-02
        1.2.7 Others
    1.3 Global Alpha- Antitrypsin Deficiency Treatment Market by Application/End Users
        1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.1 Clinic
        1.3.2 Hospital
        1.3.3 Others
    1.4 Global Alpha- Antitrypsin Deficiency Treatment Market by Region
        1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
        1.4.3 Europe Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
        1.4.4 China Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
        1.4.5 Japan Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
        1.4.7 India Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Alpha- Antitrypsin Deficiency Treatment (2013-2025)
        1.5.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2025)
        1.5.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2025)

2 Global Alpha- Antitrypsin Deficiency Treatment Competition by Players/Suppliers, Type and Application
     2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Competition by Players/Suppliers
        2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Alpha- Antitrypsin Deficiency Treatment (Volume and Value) by Type
        2.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
        2.2.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
    2.3 Global Alpha- Antitrypsin Deficiency Treatment (Volume and Value) by Region
        2.3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Region (2013-2018)
        2.3.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Region (2013-2018)
    2.4 Global Alpha- Antitrypsin Deficiency Treatment (Volume) by Application

3 United States Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    3.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        3.1.1 United States Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        3.1.2 United States Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        3.1.3 United States Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    3.2 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

4 Europe Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    4.1 Europe Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        4.1.1 Europe Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        4.1.2 Europe Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    4.2 Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

5 China Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    5.1 China Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        5.1.1 China Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        5.1.2 China Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        5.1.3 China Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    5.2 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    5.3 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    5.4 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

6 Japan Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    6.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        6.1.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        6.1.2 Japan Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    6.2 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    7.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        7.1.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    7.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

8 India Alpha- Antitrypsin Deficiency Treatment (Volume, Value and Sales Price)
    8.1 India Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
        8.1.1 India Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
        8.1.2 India Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
        8.1.3 India Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
    8.2 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Players (2013-2018)
    8.3 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type (2013-2018)
    8.4 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application (2013-2018)

9 Global Alpha- Antitrypsin Deficiency Treatment Players/Suppliers Profiles and Sales Data
    9.1 Adverum Biotechnologies, Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Alnylam Pharmaceuticals, Inc.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 Applied Genetic Technologies Corporation
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 Arrowhead Pharmaceuticals, Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Carolus Therapeutics, Inc.
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Cevec Pharmaceuticals GmbH
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Dicerna Pharmaceuticals, Inc.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 Digna Biotech, S.L.
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 Editas Medicine, Inc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 Grifols, S.A.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview
    9.11 Inhibrx
    9.12 Intellia Therapeutics, Inc.
    9.13 International Stem Cell Corporation
    9.14 Ionis Pharmaceuticals, Inc.
    9.15 Kamada Ltd.
    9.16 Polyphor Ltd.
    9.17 ProMetic Life Sciences Inc.
    9.18 rEVO Biologics, Inc.
    9.19 Sangamo BioSciences, Inc.

10 Alpha- Antitrypsin Deficiency Treatment Maufacturing Cost Analysis
    10.1 Alpha- Antitrypsin Deficiency Treatment Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
    10.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast (2018-2025)
    14.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2018-2025)
    14.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2025)
       14.3.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Forecast by Type (2018-2025)
       14.3.3 Global Alpha- Antitrypsin Deficiency Treatment Price Forecast by Type (2018-2025)
    14.4 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Alpha- Antitrypsin Deficiency Treatment
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Comparison (K Pcs) by Type (2013-2025)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (Product Category) in 2017
    Figure CT-2009 Product Picture
    Figure POL-6014 Product Picture
    Figure ARO-AAT Product Picture
    Figure ALNAAT-02 Product Picture
    Figure Others Product Picture
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Comparison (K Pcs) by Application (2013-2025)
    Figure Global Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Application in 2017
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD) by Regions (2013-2025)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Growth Rate (2013-2025)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
    Figure 2017 Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
    Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players
    Table 2017 Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Share (K Pcs) by Type (2013-2018)
    Figure Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Type (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Growth Rate by Type (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Market Share by Region (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Share by Region (2013-2018)
    Figure Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Region (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Region in 2017
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Region (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Growth Rate by Region in 2017
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Region (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region in 2017
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Market Share by Application (2013-2018)
    Table Global Alpha- Antitrypsin Deficiency Treatment Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Application (2013-2018)
    Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Figure China Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Figure India Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
    Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Players (2013-2018)
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players (2013-2018)
    Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Players in 2017
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
    Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
    Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
    Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
    Table Adverum Biotechnologies, Inc. Basic Information List
    Table Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
    Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Global Market Share (2013-2018)
    Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Global Market Share (2013-2018)
    Table Alnylam Pharmaceuticals, Inc. Basic Information List
    Table Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
    Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Global Market Share (2013-2018)
    Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Global Market Share (2013-2018)
    Table Applied Genetic Technologies Corporation Basic Information List
    Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
    Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Global Market Share (2013-2018
    Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Global Market Share (2013-2018)
    Table Arrowhead Pharmaceuticals, Inc. Basic Information List
    Table Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
    Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Global Market Share (2013-2018)
    Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Global Market Share (2013-2018)
    Table Carolus Therapeutics, Inc. Basic Information List
    Table Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2013-2018)
    Figure Carolus Therapeutics, Inc.



Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...